Description
PE-22-28 is a synthetic seven-amino-acid peptide derived from spadin and studied for its interaction with TREK-1, a two-pore-domain potassium channel involved in neuronal excitability and cellular signaling. Preclinical investigations have examined its effects on TREK-1 channel activity, peptide stability, neurogenesis-related pathways, and behavioral responses in experimental animal models.
Research involving PE-22-28 remains preclinical, and its safety and effectiveness in humans have not been established. It is not an FDA-approved drug or an established treatment for depression, mood disorders, cognitive impairment, or any other medical condition. For Research Use Only. Not for human or veterinary use, ingestion, administration, diagnostic procedures, or therapeutic applications.
Additional information
| Concentration | 5mg, 10mg |
|---|



Reviews
There are no reviews yet.